Neurol. praxi. 2020;21(5):390-394 | DOI: 10.36290/neu.2020.016

Epidemiology of Parkinson's disease

MUDr. Tereza Bartoníková1, doc. MUDr. Kateřina Menšíková, Ph.D.1, prof. MUDr. Vladimír Janout, CSc.2, prof. MUDr. Petr Kaňovský, CSc.1
1 Neurologická klinika Fakultní nemocnice a Lékařské fakulty Univerzity Palackého v Olomouci
2 Centrum vědy a výzkumu, Fakulta zdravotních věd Univerzity Palackého v Olomouci

Idiopathic (sporadic) Parkinson's disease (PD) is one of the most frequent neurodegenerative disorders. The disease has heterogenous pfenotype and origin: both endogenous (genetic) and exogenous (enviromental) factors probably participate on manifestations of the PD and many other factors are involved. However, the exact pathophyziological cause has not been indentified yet. Therefore it is exceptionally important to collect all data which could help understanding the development of the Parkinson's disease. The epidemiological data can expose factors which can be further experimentally verified. It is essential to point out that relevant data about prevalence and incidence of PD are relatively rare. Just few epidemiological studies has been conducted yet using validated methods and if so, just small groups in geographically restricted areas were examined and other studies were contucted in regions with endemic incidence od parkinsonism. However, available studies suggest that the prevalence of PN and neurodegenerative parkinsonism increases with age, estimated incidence is in the range of 10-50 cases per 100 000 per year, and the probable prevalence rate is 100-300 patients per 100 000 inhabitants.

Keywords: Parkinson´s disease, epidemiology, incidence, prevalence.

Received: December 4, 2019; Revised: March 12, 2020; Accepted: March 12, 2020; Prepublished online: March 12, 2020; Published: November 11, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartoníková T, Menšíková K, Janout V, Kaňovský P. Epidemiology of Parkinson's disease. Neurol. praxi. 2020;21(5):390-394. doi: 10.36290/neu.2020.016.
Download citation

References

  1. Baldereschi M, Di Carlo A, Rocca WA, Vanni P, Maggi S, Perissinotto E, Grigoletto F, Amaducci L, Inzitari D. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 2000; 14: 1358-1363. Go to original source... Go to PubMed...
  2. Bergareche A, De La Puente E, López de Munain A, Sarasqueta C, de Arce A, Poza JJ, Martí-Massó JF. Prevalence of Parkinson's disease and other types of Parkinsonism. A door-to-door survey in Bidasoa, Spain. J Neurol. 2004; 251: 340-345. Go to original source... Go to PubMed...
  3. Bonita R, Beaglehole R, Kjellström T, World Health Organisation. Basic Epidemiology 2nd Ed. World Health Organization, Geneve 2006.
  4. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003; 24: 197-211. Go to original source... Go to PubMed...
  5. de Rijk, Tzourio C, Breteler MM, Dartigues JF, Amaducci L, Lopez-Pousa S, Manubens-Bertran JM, Alpérovitch A, Rocca WA. Prevalence of parkinsonism and Parkinson's disease in Europe: the Europarkinson collaborative study. European community concerted action on the epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 62: 10-15. Go to original source... Go to PubMed...
  6. Elbaz A. Carcaillon L, Kab S. Epidemiology of Parkinson's disease. Revue Neurologique 2016; 14-26. Go to original source... Go to PubMed...
  7. Fall P, Axelson O, Fredriksson M, Hansson G, Lindvall B, Olsson JE, Granérus NK. Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community. J. Clin. Epidemiol. 1996; 49: 637-641. Go to original source... Go to PubMed...
  8. Fang F. Head injury and Parkinson's disease: a population-based study. Mov Disord. 2012; 27: 1632-1635. Go to original source... Go to PubMed...
  9. Fender P, Paita M, Ganay D, Benech JM. Prevalence of thirty long term disorders for French health insurance members in 1994. Rev Epidemiol Sante Publique 1997; 45: 454-464.
  10. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283-301. Go to original source... Go to PubMed...
  11. Gagne JJ. Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis. Neurology 2010; 74: 995-1002. Go to original source... Go to PubMed...
  12. Hernán MA. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol. 2002; 52: 276-84. Go to original source... Go to PubMed...
  13. Hirsch L. The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis. Neuroepidemiology. 2016; 46: 292-300. Go to original source... Go to PubMed...
  14. Hofman A, Collette HJ, Bartelds AI. Incidence and risk factors of Parkinson's disease in The Netherlands. Neuroepidemiol. 1989; 8: 296-299. Go to original source... Go to PubMed...
  15. HorsfallIrene L, PetersenK, Schrag WA. Time trends in incidence of Parkinson's disease diagnosis in UK primary care. J Neurol. 2013; 260: 1351-1357. Go to original source... Go to PubMed...
  16. Hughes AJ, Daniel SE, Kilford L. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184. Go to original source... Go to PubMed...
  17. Chen H. Smoking duration, intensity, and risk of Parkinson dinase. Neurology 2010; 74: 878-84. Go to original source... Go to PubMed...
  18. Janout V. Základy epidemiologie. Universita Palckého 1995.
  19. Kollárová H. Vybrané kapitoly z epidemiologie. Univerzita Palackého v Olomouci 2011.
  20. MacDonald BK, Cockerell OC, Sander JWAS, Shorvon SD. The incidence and lifetime prevalence of neurological disirders in a prospective community based study in the UK. Brain 2000; 123: 665-676. Go to original source... Go to PubMed...
  21. Ma CL, Su L, Xie JJ, Long JX, Wu P, Gu L. The prevalence and incidence of Parkinson's disease in China: a systematic review and meta-analysis. J Neural Transm (Vienna) 2014; 121: 123-134. Go to original source... Go to PubMed...
  22. Menšíková K. Bareš M, Kaňovský P. Atypické parkinsonské syndromy. Galén, Praha 2015.
  23. Menšíková K. Prevalence of neurodegenerative parkinsonism in an isolated population in south-eastern Moravia, Czech Republic. Eur J Epidemiol 2013; 28: 833-836. Go to original source... Go to PubMed...
  24. Moisan F, Sofiane K, Fatima M, Marianne C, Morgane L, Cécile Q, Laure C, Javier N, Nicolas D, Archana SM, Marjorie B-Z, Elbaz A. Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. J Neurol Neurosurg Psychiatry 2016; 87: 952-957. Go to original source... Go to PubMed...
  25. Muangpaisan W, Hori H, Brayne C. Systematic review of the prevalence and incidence of Parkinson's disease in Asia. J Epidemiol. 2009; 19: 281-93. Go to original source... Go to PubMed...
  26. Nutt JG. Motor subtype in Parkinson's disease: different disorders or different stages of disease? Mov Disord. 2016; 3: 957-961. Go to original source... Go to PubMed...
  27. Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehéricy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ. Past, present, and future of Parkinson's disease: a special essay on the 200th anniversary of the shaking palsy. Mov Disord. 2017; 32: 1264-1310. Go to original source... Go to PubMed...
  28. Okubadejo NU. Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studies Mov Disord. 2006; 2: 2150-2156. Go to original source... Go to PubMed...
  29. Pezzoli G. Exposure to pesticides or solvents and risk of Parkinson disease. Neurology 2013; 80: 2035-2041. Go to original source... Go to PubMed...
  30. Politis M, Sauerbier A, Loane C, Pavese N, Martin A, Corcoran B, Brooks DJ, Ray-Chaudhuri K, Piccini P. Sustained striatal dopamine levels following intestinal levodopa infusions in Parkinson's disease patients. Mov Disord. 2017; 32: 235-240. Go to original source... Go to PubMed...
  31. Pringsheim T. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014; 29: 1583-1590. Go to original source... Go to PubMed...
  32. Ruiping Xia, Zhi-Hong Mao. Progression of motor symptoms in Parkinson's disease. Neurosci Bull February. 2012; 28: 39-48. Go to original source... Go to PubMed...
  33. Sääksjärvi K. Prospective study of coffee consumption and risk of Parkinson's disease. Eur J Clin Nutr. 2008; 62: 908-915. Go to original source... Go to PubMed...
  34. Sauerbier A, Mubasher AQ, Rajah T. Chaudhuri K.R. New concepts in the pathogenesis and presentation of Parkinson´s disease. Clin Med. 2016; 4: 365-370. Go to original source... Go to PubMed...
  35. Schrag A, Ben-Shlomo Y, Quinn N P. Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London BMJ 2000; 321: 21. Go to original source... Go to PubMed...
  36. Schoenberg BS. Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology 1988; 38: 645-646. Go to original source... Go to PubMed...
  37. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997; 388: 839-840. Go to original source... Go to PubMed...
  38. Stoessl AJ. Positron emission tomography in premotor Parkinson's disease. Park Relat Disord. 2007; 421-424. Go to original source... Go to PubMed...
  39. Trenkwalder C, Schwarz J, Gebhard J, Ruland D, Trenkwalder P, Hense HW, Oertel WH. Starnberg Trial on Epidemiology of Parkinsonism and Hypertension in the Elderly: Prevalence of Parkinson's Disease and Related Disorders Assessed by a Door-to-Door Survey of Inhabitants Older Than 65 Years. Arch Neurol. 1995; 52: 1017-1022. Go to original source... Go to PubMed...
  40. Sveinbjornsdottir S. The clinical symptoms of Parkinson's disease. J Neurochem. 2016; 139: 318-324. Go to original source... Go to PubMed...
  41. Van Maele-Fabry G. Occupational exposure to pesticides and Parkinson's disease: a systematic review and meta-analysis of cohort studies. Back to Results Environment International 2012; 46: 30-43. Go to original source... Go to PubMed...
  42. van de Vijver D, Roos R, Jansen P , Porsius A , de Boer A. Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records.PDS Pharmacoepidemiolog. Drug Safety 2001; 10: 549-554. Go to original source... Go to PubMed...
  43. Viñes JJ, Larumbe R, Gaminde I, Artázcoz MT. Incidence of idiopathic and secondary Parkinson disease in Navarre. Population-based case registry. Neurologia 1999; 14: 16-22. Go to PubMed...
  44. von Campenhausen S. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol. 2005; 15: 473-490. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.